Patch testing in non-immediate cutaneous adverse drug reactions: value of extemporaneous patch tests.
Haudrey AssierLaurence Valeyrie-AllanoreGwendeline GenerMuriel Verlinde CarvalhOlivier ChosidowPierre WolkensteinPublished in: Contact dermatitis (2017)
Our series yielded results similar to those of published series concerning the types of CADR and the drugs responsible. Our results suggest that, for CADRs, if a patient supplies a suspected drug but if the pharmaceutical material and staff are not available for conventional PTs, extemporaneous PTs performed by the nurse with the commercial drug used by the patient can be useful and reliable.